Avera Health and Sema4 Announce Data-driven Study to Advance Cancer Treatment Across the Avera Service Area

3 years ago

The wide-ranging Avera/Sema4 Oncology and Analytics Protocol (ASAP) study is expected to enable precision oncology care for thousands of patientsSIOUX FALLS,…

WIMI Hologram Academy: Interior Home Design Based on Virtual Reality Technology of Computer Animation

3 years ago

HONG KONG, June 01, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…

KemPharm Announces Research Affirming Serdexmethylphenidate’s Lower Potential for Abuse Featured in Peer-Reviewed Publication, Current Medical Research & Opinion

3 years ago

Three clinical studies demonstrated serdexmethylphenidate (SDX), KemPharm’s prodrug of d-methylphenidate (d-MPH), yielded significantly lower abuse-related effects compared to d-MPH CELEBRATION,…

Summit Therapeutics Appoints Ankur Dhingra as Chief Financial Officer

3 years ago

Cambridge, MA, June 01, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Ankur Dhingra has been appointed…

Biomea Fusion to Present New Preclinical Data on BMF-219 in Two Diabetic Animal Models at ADA 2022

3 years ago

Company to host virtual investor R&D event on Monday, June 6, 2022 at 4:05 PM EDT featuring covalent menin inhibitor,…

IntelGenx Announces Intention to Issue Shares in Payment of Principal and Interest on Outstanding Debentures

3 years ago

SAINT LAURENT, Quebec, June 01, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) announces that…

PLx Pharma Inc. to Present at JMP Securities 2022 Life Sciences Conference on June 15, 2022

3 years ago

SPARTA, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug…

SomaLogic Announces June Conference Participation

3 years ago

BOULDER, Colo., June 01, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that…

Phathom Pharmaceuticals to Present at the 2022 Jefferies Healthcare Conference

3 years ago

FLORHAM PARK, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing…

Clearmind Medicine Granted Patent Approval for Psychedelic- Based Alcohol Substitute in India

3 years ago

The patent was granted by India’s Office of the Controller-General of Patents, Designs and Trademarks VANCOUVER, June 01, 2022 (GLOBE…